Democratizing hedge fund level analysis tools for everyone
| Name | Ikapharmindo Putramas Tbk. |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| PT. Ikapharma Inti Mas | 78.12 | 78.12 |
| Public < 5% | 20.19 | 20.19 |
| Dra. Maudy Ratna Winata | 0.88 | 0.88 |
| Drs. Titianus Winata | 0.62 | 0.62 |
| Augustina Winata | 0.19 | 0.19 |
| Eliza Arlena Winata | 0.19 | 0.19 |
| Source | 2022 | 2021 |
|---|---|---|
| 2598 | IKPM | F2 |
| 2599 | IKPM | F2 |
| 2600 | IKPM | F2 |
| 2601 | IKPM | F2 |
| Region | 2022 | 2021 |
|---|---|---|
| 1550 | IKPM | F2 |
| 1551 | IKPM | F2 |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 1.29 | # 8 / 15 |
| EV_EBITDA | -28.64 | --- / 15 |
| PER | -10.45 | --- / 15 |
| PBV | 2.15 | # 9 / 15 |
| DER | 1.10 | # 7 / 15 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | -12.43 | --- / 15 |
| ROA % | -9.47 | --- / 15 |
| ROE % | -20.669999999999998 | --- / 15 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2024 | 2.25 | 0.9 |
| Timeframe | Performance |
|---|---|
| 1W % | -6.4 |
| 1Mo % | 23.6 |
| 3Mo % | 17.0 |
| 1Yr % | -1.5 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 14.94 | 52.43 T | 53.67 T | 34,651 B | 5,348 B | 3,508 B |
| SOHO | 57.58 | 33.76 T | 36.00 T | 10,566 B | 742 B | 587 B |
| SIDO | 14.43 | 15.75 T | 15.31 T | 3,639 B | 1,481 B | 1,091 B |
| TSPC | 8.35 | 12.67 T | 11.15 T | 13,512 B | 2,016 B | 1,515 B |
| PYFA | -9.55 | 4.67 T | 10.70 T | 2,747 B | -142 B | -488 B |
| MDLA | 8.92 | 3.45 T | 6.04 T | 14,788 B | 557 B | 386 B |